Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
- PMID: 20452100
- PMCID: PMC2990809
- DOI: 10.1016/j.neurobiolaging.2010.01.010
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
Abstract
Many elderly individuals remain dementia-free throughout their life. However, some of these individuals exhibit Alzheimer disease neuropathology on autopsy, evidenced by neurofibrillary tangles (NFTs) in AD-specific brain regions. We conducted a genome-wide association study to identify genetic mechanisms that distinguish non-demented elderly with a heavy NFT burden from those with a low NFT burden. The study included 299 non-demented subjects with autopsy (185 subjects with low and 114 with high NFT levels). Both a genotype test, using logistic regression, and an allele test provided consistent evidence that variants in the RELN gene are associated with neuropathology in the context of cognitive health. Immunohistochemical data for reelin expression in AD-related brain regions added support for these findings. Reelin signaling pathways modulate phosphorylation of tau, the major component of NFTs, either directly or through β-amyloid pathways that influence tau phosphorylation. Our findings suggest that up-regulation of reelin may be a compensatory response to tau-related or beta-amyloid stress associated with AD even prior to the onset of dementia.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures




References
-
- Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997;18(4 Suppl):S1–2. - PubMed
-
- Bar I, Lambert de Rouvroit C, Goffinet AM. The evolution of cortical development. An hypothesis based on the role of the Reelin signaling pathway. Trends Neurosci. 2000;23(12):633–8. - PubMed
-
- Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64(5):834–41. - PubMed
-
- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–59. - PubMed
WEB References
Publication types
MeSH terms
Substances
Grants and funding
- P50-AG08671/AG/NIA NIH HHS/United States
- P30 AG028377/AG/NIA NIH HHS/United States
- P50 AG008671/AG/NIA NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- P30-AG008017/AG/NIA NIH HHS/United States
- R01-AG17917/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P50-AG05681/AG/NIA NIH HHS/United States
- U01-AG016976/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- P50-AG05131/AG/NIA NIH HHS/United States
- R01-AG026916/AG/NIA NIH HHS/United States
- P01-AG03991/AG/NIA NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- P50-AG005146/AG/NIA NIH HHS/United States
- P30-AG10161/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P50-AG16574/AG/NIA NIH HHS/United States
- P30-AG028377/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30-AG10129/AG/NIA NIH HHS/United States
- P30-AG028383/AG/NIA NIH HHS/United States
- R01 AG026916/AG/NIA NIH HHS/United States
- U01-AG06786/AG/NIA NIH HHS/United States
- U01 AG006786/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical